Admetsys
Admetsys is pioneering the future of critical care through high-precision automation, adapting to individual patient needs and implementing clinician-set goals automatically. Their innovative clinical robotics system is designed for blood analysis and metabolic control in critical care and surgery, aiming to improve patient outcomes and reduce clinical workload.
What We Do
A clinical automation controller that captures data from biosensors, constructs a real-time AI model of each patient's metabolism, and autonomously regulates glucose levels with optimized insulin and dextrose therapy.
Provides real-time continuous blood diagnostics with a cartridge-based design, enabling early detection of sepsis and supporting glucose regulation.
Application Area
Show More (2)Digital Health Technologies
Show More (1)Diagnostics
Key People
News & Updates
Admetsys has received FDA Breakthrough designation, which accelerates the introduction of their fully autonomous clinical robotics in hospitals.
Admetsys has obtained CE Mark approval for their PrecisionOne™ system, allowing for its commercial use in the EU and EEA.